HomeASBPW • NASDAQ
add
Aspire Biopharma Holdings Inc.
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 799.89K | 725.28% |
Net income | -1.98M | -1,944.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 206.23K | 951.99% |
Total assets | 989.42K | -80.44% |
Total liabilities | 10.61M | 129.73% |
Total equity | -9.62M | — |
Shares outstanding | 49.53M | — |
Price to book | -0.37 | — |
Return on assets | -135.35% | — |
Return on capital | 300.28% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.98M | -1,944.19% |
Cash from operations | -1.14M | -1,927.43% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.14M | -4,019.17% |
Free cash flow | -1.02M | — |
About
Founded
2021
Website
